GO
Loading...

Believe in strong Europe reimbursement: Dendreon CEO

Wednesday, 5 Mar 2014 | 5:29 PM ET

Biotech firm Dendreon is set to begin selling its prostate cancer vaccine "Provenge" in Europe. John Johnson, Dendreon chairman & CEO, discusses the European launch and addresses investor concerns.